33.

The exposure assessment shall be based on the information in the technical dossier provided in conformity with Articles 6 and 21 and on any other available and relevant information. Particular account shall be taken, as appropriate, of: adequately measured exposure data, the form in which the biocidal product is marketed, the type of biocidal product, the application method and application rate, the physico-chemical properties of the biocidal product, the likely routes of exposure and potential for absorption, the frequency and duration of exposure, maximum residue levels, the type and size of specific exposed populations, where such information is available.

← anx_VI__cpt_1__cpt_3__cpt_2__cpt_1__point_32__text_1 · All articles · anx_VI__cpt_1__cpt_3__cpt_2__cpt_1__point_33__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-10-29 · Text as adopted (Official Journal); later amendments are not incorporated in this text.